Close

Next-Gen Repertoire Analysis Services: Comprehensive Immune Profiling Solutions

Background Service Portfolio Platform Application Advantage Related Service FAQ Online Inquiry

In the era of precision medicine, understanding the vast diversity of the immune system is paramount for drug discovery and therapeutic development. Creative Biolabs, a global leader in biotechnology with over two decades of expertise, provides a world-class Repertoire Analysis Service. Leveraging our advanced high-throughput sequencing platform and proprietary bioinformatics pipelines, we empower researchers to explore the dynamic landscape of T-cell receptors (TCRs) and B-cell receptors (BCRs) with unprecedented resolution. Our services are designed to support the discovery of novel biomarkers, the development of therapeutic antibodies, and the monitoring of immune responses in various disease contexts.

Discuss Your Project Today

The Power of High-Throughput Sequencing in Repertoire Analysis

Traditional methods for immune profiling often lack the depth required to capture the full spectrum of immune diversity. At Creative Biolabs, we utilize NGS sequencing and high-throughput sequencing to provide a quantitative and qualitative view of the immune repertoire.

Table 1. Comparison of Repertoire Analysis Platforms

Feature Traditional Sanger Sequencing Creative Biolabs High-Throughput Platform
Throughput Low (tens of clones) Ultra-high (millions of reads)
Sensitivity Low Extremely High (detects rare clones)
Pairing Information No (unless laborious) Computational Inference
Data Complexity Simple Complex / Bioinformatics driven
Cost per Clone High Low

Our Comprehensive Service Portfolio of Repertoire Analysis

Creative Biolabs offers a modular and customizable suite of services to meet the specific needs of your project. Explore our specialized sub-pages for in-depth technical information:

Cutting-Edge Technologies & Strategies of Our Repertoire Analysis Services

Advanced NGS Sequencing Strategies

We employ diverse NGS sequencing strategies, including 5' RACE (Rapid Amplification of cDNA Ends) and multiplex PCR. The 5' RACE approach is particularly advantageous as it minimizes PCR bias and captures the full V(D)J sequence, including the leader sequence, ensuring an unbiased representation of the Repertoire Analysis Services.

Fig. 1 High-throughput sequencing. (Creative Biolabs Authorized)

High-Throughput Sequencing Platform

Our facility is equipped with the latest equipment platforms. While this platform provides the high depth necessary for frequency analysis, and offers long-read sequencing that covers the entire transcript, facilitating better assembly of complex regions.

AI-Driven Bioinformatics Pipeline

Raw data is just the beginning. Our bioinformatics team utilizes machine learning algorithms to:

Applications of Repertoire Analysis

The insights gained from Repertoire Analysis Services are transformative across multiple biological domains:

Therapeutic Antibody Discovery

By analyzing the antibody repertoire of immunized animals or convalescent patients, we can rapidly identify high-affinity lead candidates. This bypasses traditional hybridoma limitations and accelerates the MemDX™ Therapeutic Antibody Discovery process.

Immunotherapy & Vaccine Development

Monitoring TCR repertoire changes post-vaccination or during CAR-T therapy provides critical data on immune activation, persistence, and clonal dominance.

Autoimmune & Infectious Disease Research

Identifying "public clones" (sequences shared between individuals) helps in understanding the common immune molecular patterns in response to specific pathogens or autoantigens.

Why Choose Creative Biolabs?

Explore Our Comprehensive Services

Creative Biolabs offers a modular suite of services tailored to address diverse research questions:

Creative Biolabs remains committed to providing the most advanced Repertoire Analysis Service in the industry. Our blend of veteran expertise and cutting-edge technology ensures that your research stays at the forefront of the biological sciences. Contact us today to discuss how we can accelerate your next breakthrough.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

  1. Q: What is the minimum sample requirement for Repertoire Analysis?

    A: Typically, we require at least 1×105 to 1×106 cells for a robust analysis, but we have optimized protocols for "small lymphocyte" populations with lower counts.

  2. Q: How do you handle PCR bias in NGS sequencing?

    A: We primarily utilize 5' RACE and integrate Unique Molecular Identifiers (UMIs) during library preparation to track and correct PCR amplification bias, ensuring quantitative accuracy.

  3. Q: Can you provide TCR alpha/beta pairing information?

    A: Yes, through our single-cell high-throughput sequencing platform, we can provide native pairing of TCR alpha/beta or BCR heavy/light chains.

  4. Q: Which species do you support?

    A: We offer standard services for Human, Mouse, Rat, and Non-Human Primates (NHP). Custom primer design is available for other species like Camelids, Rabbits, and Chickens.

  5. Q: Do you provide bioinformatic support for data I already have?

    A: Absolutely. Our bioinformatics team offers standalone Repertoire Analysis services for data generated on other platforms.

  6. Q: How deep should I sequence my repertoire?

    A: Depth depends on the sample complexity. For a standard human PBMC sample, we typically recommend 2-5 million reads to capture the majority of the diversity.

  7. Q: Are your services compliant with clinical diagnostic standards?

    A: Our services are intended for research use only (RUO). We provide high-quality data for discovery and preclinical phases but do not offer clinical diagnostic reports.

  8. Q: How do I get a quote for my project?

    A: Simply contact our technical team with your sample type, species, and target, and we will provide a detailed proposal within 24 hours.

Reference

  1. Takahashi, Hiroyuki, et al. "The current status of T cell receptor (TCR) repertoire analysis in colorectal cancer." International Journal of Molecular Sciences 26.6 (2025): 2698. https://doi.org/10.3390/ijms26062698

×
Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us